Immunotech Biopharm Ltd

HKEX:6978.HK

1.6 (HKD) • At close November 14, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q1
Assets:
Current Assets:
Cash & Cash Equivalents 79.64579.64552.16152.161133.74133.7458.44858.448215.968215.968353.341353.341458.468458.468845.386845.386174.229174.229282.247282.247-174.022
Short Term Investments 65.66565.665124.812124.812133.136110.84721.0121.01166.506000100.58100.58000000348.044
Cash and Short Term Investments 145.31145.31176.973176.973266.876266.87679.45879.458215.968215.968353.341353.341559.048559.048845.386845.386174.229174.229282.247282.247174.022
Net Receivables 000000000000000000000
Inventory 6.8516.8514.9244.9246.1966.1967.2137.21310.20910.20910.86610.8668.3358.3353.9753.9753.5623.5624.814.810
Other Current Assets 28.66928.66931.99731.99743.15143.15131.44331.44336.76936.76947.99347.99353.30753.30734.36234.36230.13430.13421.09321.0930
Total Current Assets 180.83180.83213.894213.894316.223316.223118.114118.114262.946262.946412.2412.2620.69620.69883.723883.723207.925207.925308.15308.15174.022
Non-Current Assets:
Property, Plant & Equipment, Net 474.253474.253500.759500.759505.598505.598527.251527.251461.398461.398426.588426.588201.321201.321154.492154.492131.641131.64185.3585.350
Goodwill 000042.81200035.417000000000000
Intangible Assets 21.4121.4141.88241.8820.04342.85542.48642.4860.03535.45214.2514.258.2248.2247.3717.3717.8217.8217.7677.7670
Goodwill and Intangible Assets 21.4121.4141.88241.88242.85542.85542.48642.48635.45235.45214.2514.258.2248.2247.3717.3717.8217.8217.7677.7670
Long Term Investments 000.04646.362-4.366128.77119.165140.1750.167166.673163.176163.17681.389181.969131.969131.96900000
Tax Assets 0089.659000-119.1650-0.1670-163.176000-131.969000000
Other Non-Current Assets 43.22643.2260.04343.387177.4844.344191.58651.411217.75151.078244.65181.475185.67685.096164.64332.67417.08317.08315.70415.704-174.022
Total Non-Current Assets 538.889538.889632.39632.39721.567721.567761.323761.323714.601714.601685.489685.489476.61476.61326.506326.506156.545156.545108.821108.821-174.022
Total Assets 719.719719.719846.284846.2841,037.791,037.79879.437879.437977.547977.5471,097.6891,097.6891,097.31,097.31,210.2291,210.229364.47364.47416.971416.9710
Liabilities & Equity:
Current Liabilities:
Account Payables 55.05755.05746.7646.7634.33834.33837.39437.39438.31538.31532.15232.15217.6417.645.845.843.6973.6974.6324.6320
Short Term Debt 312.079312.079-107.16124.67925.19525.19526.05626.05621.78321.78320.20920.2098.9818.981-7.837.2043.7173.7173.7863.7860
Tax Payables 000000000000000000000
Deferred Revenue 042.843131.840000000000015.034050.02019.21200
Other Current Liabilities 111.07111.070.157131.997115.002115.002145.024145.024109.601109.601127.74127.7417.28517.2853.53918.573197.5256.018178.5425.6450
Total Current Liabilities 478.206478.206203.436203.436174.535174.535208.474208.474169.699169.699180.101180.10143.90643.90631.61731.617254.95463.432206.1734.0630
Non-Current Liabilities:
Long Term Debt 97.2297.22432.494432.494435.989435.989123.75123.7579.58179.58190.84590.84543.67343.67343.85643.85633.30533.30535.21435.2140
Deferred Revenue Non-Current 0039.464039.499040.844044.70303.56403.85305.90804.8305.25200
Deferred Tax Liabilities Non-Current 00-0.03900.32100.00100.00105.80-3.8530-2.5040-1.0710-1.13800
Other Non-Current Liabilities 65.95965.95939.46439.464039.499040.844044.70303.56403.8535.9085.9084.834.835.2525.2520
Total Non-Current Liabilities 163.179163.179471.958471.958475.488475.488164.594164.594124.284124.28494.40994.40947.52647.52649.76449.76438.13538.13540.46640.4660
Total Liabilities 641.385641.385675.394675.394650.023650.023373.068373.068293.983293.983274.51274.5191.43291.43281.38181.381293.089101.567246.63674.5290
Equity:
Preferred Stock 0000000000583.8160401.210610.9940191.522191.522172.107172.1070
Common Stock 3.5763.5763.5763.5763.5763.5763.5763.5763.5763.5763.5763.5763.5763.5763.5763.5760.6770.6770.6770.6770
Retained Earnings -1,710.661-1,710.661-1,620.147-1,618.146-1.401-1,401.441-1.283-1,283.327-1.106-1,105.546-965.218-965.218-758.29-758.29-610.994-610.994-260.8810-171.947-171.9470
Accumulated Other Comprehensive Income/Loss 385.688385.6880.17385.6870.386385.6880.386385.6870.384383.986381.402381.402357.08357.08-28.42332.45769.35969.359-15.9180.754214.651
Other Total Stockholders Equity 1,402.4981,402.4981,402.4991,402.499387.7611,402.4971,402.4991,402.4991,402.4981,402.498234.8671,402.499600.0791,402.499791.5041,402.498260.8810159.458159.4581.646
Total Shareholders Equity 81.10181.101173.616173.616390.321390.32508.435508.435684.514684.514822.259822.2591,004.8651,004.8651,127.5371,127.53770.036261.558168.942341.049216.297
Total Equity 78.33478.334170.89170.89387.767387.766506.369506.369683.564683.564823.179823.1791,005.8681,005.8681,128.8481,128.84871.381262.903170.335342.442216.297
Total Liabilities & Shareholders Equity 719.719719.719846.284846.2841,037.791,037.789879.437879.437977.547977.5471,097.6891,097.6891,097.31,097.31,210.2291,210.229364.47364.47416.971416.971216.297